FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美高梅中國控股有限公司(於開曼群島註冊成立的有限公司) 呈交日期： 2025年8月11日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02282 | 說明 普通股 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | 佔有關事件前的現有已發 | 庫存股份變動 | 每股發行 ...

证券时报·数据宝统计显示，8月8日有8家香港上市公司进行了股份回购，合计回购417.30万股，回购金 额5175.50万港元。 恒生银行回购数量20.00万股，回购金额2286.94万港元，回购最高价为114.700港元，最低价为113.800港 元，年内累计回购金额1.36亿港元；美高梅中国回购数量100.00万股，回购金额1636.21万港元，回购最 高价为16.580港元，最低价为16.110港元，年内累计回购金额3853.95万港元；百胜中国回购数量1.75万 股，回购金额627.07万港元，回购最高价为363.800港元，最低价为357.600港元，年内累计回购金额 10.76亿港元。 以金额进行统计，8月8日回购金额最多的是恒生银行，回购金额为2286.94万港元；其次是美高梅中 国，回购金额为1636.21万港元；回购金额居前的还有百胜中国、元征科技等。回购数量上看，8月8日 回购股数最多的是枫叶教育，当日回购量为234.20万股；其次是美高梅中国、元征科技等，回购数量分 别为100.00万股、27.95万股。 值得关注的是，本次回购627.07万港元的百胜中国，年内则进行多次回购，合计回购金额 ...

Group 1 - The article reports on share buybacks conducted by several companies on August 8, 2025, with Hang Seng Bank having the largest buyback amount of 22.8694 million HKD for 200,000 shares [1][2] - The total number of shares repurchased by each company and their respective buyback amounts are detailed, indicating a trend of companies engaging in share repurchase programs [2] - The cumulative buyback numbers for the year are provided, showing the percentage of total shares repurchased relative to the company's total share capital [2] Group 2 - Hang Seng Bank (00011) repurchased 200,000 shares, totaling 22.8694 million HKD, with a year-to-date cumulative buyback of 1.2 million shares, representing 0.064% of its total share capital [2] - MGM China (02282) repurchased 1 million shares for 16.3621 million HKD, with a cumulative buyback of 2.6275 million shares, accounting for 0.069% of its total share capital [2] - Yum China (09987) conducted two buybacks, totaling 17,500 shares for 9.4707 million HKD, with a cumulative buyback of 4.1215 million shares, representing 1.110% of its total share capital [2]

Summary of Key Points Core Viewpoint - MGM China has been actively repurchasing its shares, indicating a strategy to enhance shareholder value amidst market fluctuations [2]. Share Buyback Details - On August 8, MGM China repurchased 1 million shares at a price range of HKD 16.110 to HKD 16.580, totaling HKD 16.36 million [2]. - The stock closed at HKD 16.120 on the same day, reflecting a decline of 6.93%, with a total trading volume of HKD 371 million [2]. - Year-to-date, the company has conducted four buybacks, accumulating a total of 3.0022 million shares repurchased for a total amount of HKD 38.5395 million [2]. Buyback Breakdown - The detailed buyback transactions are as follows: - August 8, 2025: 100,000 shares at a maximum price of HKD 16.580 and a minimum price of HKD 16.110, totaling HKD 1.63621 million [2]. - June 18, 2025: 100,000 shares at a maximum price of HKD 11.300 and a minimum price of HKD 11.140, totaling HKD 1.12380 million [2]. - June 16, 2025: 62,750 shares at a maximum price of HKD 10.900 and a minimum price of HKD 10.660, totaling HKD 0.67470 million [2]. - March 21, 2025: 37,470 shares at a maximum price of HKD 11.280 and a minimum price of HKD 11.120, totaling HKD 0.41924 million [2].

Group 1 - MGM China announced a share buyback plan to repurchase 1 million shares at a cost of approximately HKD 16.36 million on August 8, 2025 [1]

Core Viewpoint - MGM China Holdings Limited (02282) announced a share repurchase plan, intending to buy back 1 million shares at an estimated cost of approximately HKD 16.36 million on August 8, 2025 [1] Company Summary - The company plans to execute the buyback of 1 million shares, reflecting a strategic move to enhance shareholder value [1] - The total expenditure for this repurchase is projected to be around HKD 16.36 million, indicating the company's commitment to returning capital to its shareholders [1]

Group 1 - MGM China announced a share buyback of 1 million shares at a cost of HKD 16.36 million on August 8 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美高梅中國控股有限公司(於開曼群島註冊成立的有限公司) 呈交日期： 2025年8月8日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02282 | 說明 | 普通股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | 事件 | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | | | 已發行 ...

Market Overview - The Hong Kong stock market experienced a decline, with the Hang Seng Index falling over 200 points, closing below 25,000 points, and the Hang Seng Technology Index dropping by 1.56% [1] - Major technology stocks saw a broad decline, with Alibaba down 2.4% and JD.com down 1.44% [2] Sector Performance - The semiconductor sector faced significant losses, with SMIC dropping over 8%, marking the worst performance in the sector [4] - Gaming stocks also fell sharply, with Wynn Macau down over 7% and MGM China down over 6% [6] - The paper industry saw declines, with Chenming Paper down over 8% [7] - Innovative drug stocks continued to decline, with Hutchison China MediTech down over 15% and Zai Lab down over 10% [8] Positive Performances - Gold stocks led gains in the metals sector, with Zhaojin Mining and Lingbao Gold both rising over 3% [3][10] - Heavy machinery stocks showed resilience, with Zhonglian Heavy Industry rising nearly 6% [3] - Cement stocks performed well, with Shanshui Cement up over 6% [9] - Wind power stocks also saw increases, with Goldwind Technology rising over 10% [11] Capital Flows - Southbound funds recorded a net inflow of 6.271 billion HKD, with the Shanghai-Hong Kong Stock Connect contributing 3.28 billion HKD and the Shenzhen-Hong Kong Stock Connect contributing 2.992 billion HKD [12] Future Outlook - Huatai Securities suggests that the recent pullback in the Hong Kong market is due to adjustments in expectations, but the medium-term liquidity remains accommodative. They recommend focusing on sectors with improving conditions and low valuations, particularly in technology [13]

Group 1: Semiconductor Industry - Citi maintains an "outperform" rating for SMIC with a target price of HKD 59.2, reporting a 1.7% quarter-over-quarter revenue decline to USD 2.21 billion, which is better than expected. Gross margin was 20.4%, exceeding the 18-20% forecast range, while net profit was USD 132.5 million, 24% below market expectations. Q3 revenue is expected to grow by 7% quarter-over-quarter to USD 2.34 billion, slightly below market expectations [1] - Citi maintains an "outperform" rating for Hua Hong Semiconductor, raising the target price to HKD 50.5. The company began price adjustments in Q2, which are expected to reflect in the second half, leading to a single-digit increase in average selling prices. The 2026 and 2027 earnings forecasts were raised by 18% and 12%, respectively, while the 2023 earnings forecast was lowered by 31% due to increased taxes [2] Group 2: Pharmaceutical Industry - CMB International maintains a "buy" rating for BeiGene with a target price of HKD 225, noting that Q2 2025 performance exceeded expectations, with core product sales continuing to grow. The company is positioned as a benchmark for Chinese innovative drugs, with strong global sales of its products. The second half of 2025 is expected to be a critical period for new product approvals and clinical data releases, which may catalyze stock price growth [2] Group 3: Gaming and Hospitality Industry - CICC maintains an "outperform" rating for MGM China, reporting Q2 2025 results that exceeded expectations, with net income and adjusted EBITDA recovering to pre-pandemic levels, driven by strong performance in Macau. Management expects continued strong performance during the summer and is focused on product updates and high-end market segments [3] Group 4: Telecommunications Infrastructure - CICC maintains a "strong buy" rating for China Tower, highlighting its position as a global leader in communication infrastructure. The company's strategic layout and shared mechanisms are expected to release significant profits as existing assets depreciate. Long-term growth is anticipated from new business drivers and deepened sharing mechanisms [4] Group 5: Consumer Goods Industry - CICC maintains an "outperform" rating for Uni-President China, reporting H1 2025 results that exceeded market expectations. The beverage business remains stable amid increased competition, while the food business continues to grow. Cost advantages and improved capacity utilization are driving margin improvements, with a steady growth trend expected for the year [5] Group 6: Technology Industry - CICC maintains an "outperform" rating for Xiaomi Group with a target price of HKD 70, forecasting a 64.84% year-over-year increase in adjusted net profit for Q2 2025. The company remains among the top three globally in smartphone shipments, with strong IoT revenue expected. The release of new production capacity is anticipated to enhance order delivery [6] - CICC maintains a "buy" rating for AsiaInfo Technologies, noting that while H1 2025 revenue was pressured by cost-cutting measures from operators, innovative business trends are positive. Revenue from AI model applications and delivery services is expected to grow significantly, helping to stabilize overall revenue [7] Group 7: Robotics Industry - CICC initiates coverage on Yujiang with an "outperform" rating and a target price of HKD 61, highlighting the company's focus on collaborative robots and product line expansion. The company is expected to show significant growth potential and diverse international business layouts [8] Group 8: Medical Services Industry - Citi maintains an "outperform" rating for Tigermed with a target price of HKD 62.6, noting an 83% increase in stock price year-to-date as the Chinese innovative drug market improves. Net profit forecasts for 2025-2027 have been raised by 31%, 30%, and 30%, respectively, with positive sales growth in Q2 [9]